Opaleye Management Inc. Fulcrum Therapeutics, Inc. Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
A detailed history of Opaleye Management Inc. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 285,000 shares of FULC stock, worth $2.43 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
285,000
Previous 130,000
119.23%
Holding current value
$2.43 Million
Previous $1.23 Million
44.01%
% of portfolio
0.45%
Previous 0.3%
Shares
8 transactions
Others Institutions Holding FULC
# of Institutions
135Shares Held
59.5MCall Options Held
4.32MPut Options Held
307K-
Ra Capital Management, L.P. Boston, MA11.6MShares$99.1 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$49.9 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$26.2 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$25.3 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $444M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...